Polaryx Therapeutics holds annual shareholder meeting
Reuters2026/09/14 10:03Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Polaryx Therapeutics held its annual stockholder meeting on Sept. 10, 2026.
- Stockholders backed the board’s director slate, setting terms running through the 2029 annual meeting.
- Grant Thornton LLP was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polaryx Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-099416), on September 14, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Carney Targets CA$1 Trillion Investment Push as Canada Summit Gets Underway
MT newswire•2026/09/14 10:53
Morgan Stanley Adjusts PT on Darden Restaurants to $255 From $236, Keeps Overweight Rating
MT newswire•2026/09/14 10:51
Waldencast plans Nasdaq delisting of warrants
Reuters•2026/09/14 10:50